EMVision Medical Devices Ltd (ASX:EMV)

Australia flag Australia · Delayed Price · Currency is AUD
1.660
-0.065 (-3.77%)
At close: Mar 6, 2026
-8.03%
Market Cap 154.28M
Revenue (ttm) 5.43M
Net Income (ttm) -10.20M
Shares Out 92.94M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 35,537
Average Volume 30,163
Open 1.670
Previous Close 1.725
Day's Range 1.635 - 1.740
52-Week Range 1.630 - 2.430
Beta 1.02
RSI 30.90
Earnings Date Feb 26, 2026

About EMVision Medical Devices

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2017
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol EMV
Full Company Profile

Financial Performance

In fiscal year 2025, EMVision Medical Devices's revenue was 5.05 million, a decrease of -54.97% compared to the previous year's 11.22 million. Losses were -9.81 million, 259.2% more than in 2024.

Financial Statements

News

There is no news available yet.